Your browser doesn't support javascript.
loading
Research advances in targeted therapy for gallbladder carcinoma / 临床肝胆病杂志
Journal of Clinical Hepatology ; (12): 2965-2969, 2023.
Article de Zh | WPRIM | ID: wpr-1003292
Bibliothèque responsable: WPRO
ABSTRACT
Gallbladder carcinoma (GBC) is a type of malignant tumor with an extremely poor prognosis, and at present, surgical operation is the most effective treatment method for this disease. Unfortunately, due to a lack of typical symptoms in the early stage, most patients have progressed to the advanced stage at the time of confirmed diagnosis and lost the opportunity for radical surgery. Among the currently available adjuvant treatments, targeted therapy has higher specificity and fewer side effects and has improved the prognosis of a variety of malignancies. With reference to the latest research advances in targeted therapy for GBC, this article reviews the current research status, potential targets, and targeted medications of targeted therapy for GBC, in order to provide a reference for the clinical treatment of GBC patients.
Mots clés
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Journal of Clinical Hepatology Année: 2023 Type: Article
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Journal of Clinical Hepatology Année: 2023 Type: Article